Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Natalizumab drug holiday in multiple sclerosis: poorly tolerated.
Killestein J, Vennegoor A, Strijbis EM, Seewann A, van Oosten BW, Uitdehaag BM, Polman CH. Killestein J, et al. Among authors: van oosten bw. Ann Neurol. 2010 Sep;68(3):392-5. doi: 10.1002/ana.22074. Ann Neurol. 2010. PMID: 20661928
Response: Brain miliary enhancement.
Bot JCJ, Mazzai L, Hagenbeek RE, Ingala S, van Oosten B, Sanchez-Aliaga E, Barkhof F. Bot JCJ, et al. Neuroradiology. 2020 May;62(5):547. doi: 10.1007/s00234-020-02404-0. Epub 2020 Mar 25. Neuroradiology. 2020. PMID: 32215682 No abstract available.
Multiple sclerosis therapy. A practical guide.
van Oosten BW, Truyen L, Barkhof F, Polman CH. van Oosten BW, et al. Drugs. 1995 Feb;49(2):200-12. doi: 10.2165/00003495-199549020-00005. Drugs. 1995. PMID: 7729328 Review.
Interleukin-2 therapy does not exacerbate multiple sclerosis.
van Oosten BW, Uitdehaag BM, Barkhof F, Hartung HP, Wagstaff J, Polman CH. van Oosten BW, et al. Neurology. 1997 Aug;49(2):633-4. doi: 10.1212/wnl.49.2.633. Neurology. 1997. PMID: 9270618 No abstract available.
75 results